Andrew D'Amico - Feb 21, 2025 Form 4 Insider Report for VICOR CORP (vicr)

Role
Director
Signature
/s/Quentin A. Fendelet Attorney in Fact for Andrew D'Amico
Stock symbol
vicr
Transactions as of
Feb 21, 2025
Transactions value $
-$83,770
Form type
4
Date filed
2/25/2025, 11:48 AM
Previous filing
Jan 23, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction vicr Common Stock Options Exercise $16.2K +1K $16.15 1K Feb 21, 2025 Direct
transaction vicr Common Stock Sale -$62K -1K -100% $62.00 0 Feb 21, 2025 Direct F1
transaction vicr Common Stock Options Exercise $13.3K +800 $16.60 800 Feb 21, 2025 Direct
transaction vicr Common Stock Sale -$51.2K -800 -100% $64.00 0 Feb 21, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction vicr Non Qualified Stock Option Options Exercise $0 -1K -100% $0.00 0 Feb 21, 2025 Common Stock 1K $16.15 Direct F2
transaction vicr Non Qualified Stock Option Options Exercise $0 -800 -100% $0.00 0 Feb 21, 2025 Common Stock 800 $16.60 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2024.
F2 This stock option is exercisable in full.